Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.
about
The transformation in biomarker detection and management of drug-induced liver injuryMiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.Improving Interpretation of New and Old Serum Biomarkers of Drug-Induced Liver Injury Through Mechanistic Modeling.Systems Toxicology Approach to Identifying Paracetamol Overdose.
P2860
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Refining Liver Safety Risk Ass ...... n Alfa (GGF2) Clinical Trials.
@en
type
label
Refining Liver Safety Risk Ass ...... n Alfa (GGF2) Clinical Trials.
@en
prefLabel
Refining Liver Safety Risk Ass ...... n Alfa (GGF2) Clinical Trials.
@en
P2093
P2860
P356
P1476
Refining Liver Safety Risk Ass ...... n Alfa (GGF2) Clinical Trials.
@en
P2093
A Caggiano
B A Howell
D J Antoine
G T Generaux
P B Watkins
R Stanulis
P2860
P304
P356
10.1002/CPT.711
P407
P577
2017-04-17T00:00:00Z